Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person An unexpected N-terminal loop in PD-1 dominates binding by nivolumab
| Class:Id | LiteratureReference:9685306 |
|---|
| _displayName | An unexpected N-terminal loop in PD-1 dominates binding by nivolumab |
|---|
| _timestamp | 2020-04-23 08:32:56 |
|---|
| author | [Person:9685324] Tan, Shuguang
[Person:5661472] Zhang, Hao
[Person:9685341] Chai, Yan
[Person:9683865] Song, Hao
[Person:9685320] Tong, Zhou
[Person:9685331] Wang, Qihui
[Person:9685317] Qi, Jianxun
[Person:9685321] Wong, Gary
[Person:9685329] Zhu, Xiaodong
[Person:9683905] Liu, William J
[Person:8848174] Gao, Shan
[Person:9685305] Wang, Zhongfu
[Person:5357832] Shi, Yi
[Person:8934888] Yang, Fuquan
[Person:6791036] Gao, George F
[Person:9685300] Yan, Jinghua |
|---|
| created | [InstanceEdit:9685307] Jassal, Bijay, 2020-04-23 |
|---|
| journal | Nat Commun |
|---|
| pages | 14369 |
|---|
| pubMedIdentifier | 28165004 |
|---|
| title | An unexpected N-terminal loop in PD-1 dominates binding by nivolumab |
|---|
| volume | 8 |
|---|
| year | 2017 |
|---|
| (literatureReference) | [Reaction:9679421] PDCD1 binds PDCD1 inhibitors [Homo sapiens]
[RegulationReference:9690985] Negative regulation by 'PDCD1:PDCD1 inhibitors [plasma membrane]' Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by An unexpected N-terminal loop in PD-1 dominates binding by nivolumab (9685306)
